One Health Perspective of Mycoplasmas: Proposals for Standardizing In Vitro PK/PD Models of Human Mycoplasma Species by Referencing Veterinary Experiences
Open Access
- 18 August 2026
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 14 (8) , 1823
Abstract
The rising prevalence of macrolide and fluoroquinolone resistance in human pathogenic mycoplasmas, such as Mycoplasma pneumoniae and Mycoplasma genitalium, threatens global public health. Mutations in 23S rRNA and quinolone resistance-determining regions (QRDR) have compromised the first-line therapies, creating an urgent clinical need for alternatives. Consequently, novel antimicrobial agents (pleuromutilins, novel tetracyclines, topoisomerase inhibitors) have become a top research priority. However, standardized in vitro pharmacokinetic/pharmacodynamic (PK/PD) methodologies for mycoplasmas remain underdeveloped compared to typical bacteria. Key challenges include the lack of a cell wall, slow growth kinetics, and fastidious culture requirements, which invalidate standard colony-counting and susceptibility testing protocols. This review evaluates current in vitro PK/PD models, quantification techniques, and key indices, highlighting the potential of adapting the methodological frameworks established in veterinary mycoplasma research (e.g., Mycoplasma bovis, Mycoplasma hyopneumoniae) to human mycoplasma species. We specifically analyze the utility of propidium monoazide (PMA)-qPCR for viability assessment and hollow-fiber infection models (HFIM) configured for small-cell retention. We conclude that harmonizing these methodologies through a One Health approach is critical for optimizing dosing regimens, reducing resistance, and accelerating the development of novel antimicrobial agents for human use.Keywords
Funding Information
- National Natural Science Foundation of China (82502755)
- Shanghai Pujiang talent program (24PJD029)
- Huadong Hospital Clinical Medical Research Center and Key Discipline Development (ZDXK2216)
This publication has 68 references indexed in Scilit:
- Pharmacokinetic/pharmacodynamic targets of ß-lactams associated with bacterial killing and suppression of the resistance emergence in the hollow fiber infection model: A systematic reviewJournal of Global Antimicrobial Resistance, 2025
- Update in Epidemiology and Management of Mycoplasma genitalium InfectionsInfectious Disease Clinics of North America, 2023
- Diagnosis and Treatment of Sexually Transmitted InfectionsJAMA, 2022
- Isolation, identification and biological characteristics of Mycoplasma bovis in yaksMicrobial Pathogenesis, 2021
- Comparison of EMA-, PMA- and DNase qPCR for the determination of microbial cell viabilityApplied Microbiology and Biotechnology, 2017
- Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniaeInternational Journal of Antimicrobial Agents, 2017
- Shaken or stirred?: Comparison of methods for dispersion of Mycoplasma pneumoniae aggregates for persistence in vivoJournal of Microbiological Methods, 2017
- Assessment of the real-time PCR and different digital PCR platforms for DNA quantificationAnalytical and Bioanalytical Chemistry, 2015
- PK/PD models in antibacterial developmentCurrent Opinion in Microbiology, 2013
- Validation of ATP luminometry for rapid and accurate titration of Mycoplasma hyopneumoniae in Friis medium and a comparison with the color changing units assayJournal of Microbiological Methods, 2010